论文信息 - Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab. - 字舞流文

Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.

I. Olivieri | G. Coniglio | P. Leccese | S. d'Angelo | P. Angela

[1] I. Olivieri,et al. Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept. , 2009, Clinical and experimental rheumatology.

[2] D. Kidd,et al. Neuro-Behçet's disease: epidemiology, clinical characteristics, and management , 2009, The Lancet Neurology.

[3] O. Maíz,et al. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease. , 2008, Clinical and experimental rheumatology.

[4] G. Akman-Demir,et al. Cyclosporine for Behçet's uveitis: is it associated with an increased risk of neurological involvement? , 2008, Clinical and experimental rheumatology.

[5] A. Silman,et al. EULAR recommendations for the management of Behçet disease , 2008, Annals of the rheumatic diseases.

[6] U. Christians,et al. Biochemical mechanisms of cyclosporine neurotoxicity. , 2004, Molecular interventions.